David Schweppe & Andy Dé

David Schweppe joined MedeAnalytics in October 2021, bringing more than 30 years of leadership experience in healthcare data, analytics and reporting. He is passionate about finding innovative business and technical solutions that can provide actionable insights to enhance the quality, affordability and value of patient care. In his role, David provides key leadership to the company’s market, product and technology strategies. Additionally, he helps customers identify and implement best in class analytical strategies and solutions to realize the value of informed data-driven decision making. Andy Dé is the Chief Marketing Officer. Andy joined MedeAnalytics in March 2021 bringing more than 20 years of enterprise software product marketing, product management and industry strategy experience. In his role, Andy oversees the company’s go-to-market (GTM) strategy and marketing. He is passionate about healthcare innovation and is recognized as an industry thought leader in healthcare.

All posts:

Proactively predicting ER visit trends with augmented analytics to improve revenues, asset utilization and patient outcomes

By David Schweppe & Andy Dé

Mission critical emergency departments (EDs) are the most valuable revenue generating asset for hospitals. While visits decreased during the pandemic, hospitals are starting to report a return to nearly pre-pandemic…

risk-based-approach-featured

Will adopting a risk-based approach with augmented analytics support care gap closure?

By David Schweppe & Andy Dé

A common challenge for healthcare systems is how to properly segment its patient populations based on risk profiles and co-morbidities. Doing this well ensures a high quality of care delivery and superior patient outcomes.

Want to talk with one of our experts?